- Home
- EXEL vs AM Comparison
EXEL vs AM Comparison
Compare EXEL & AM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- AM
- Stock Information
- Founded
- EXEL 1994
- AM 2013
- Country
- EXEL United States
- AM United States
- Employees
- EXEL N/A
- AM N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- AM Natural Gas Distribution
- Sector
- EXEL Health Care
- AM Utilities
- Exchange
- EXEL Nasdaq
- AM Nasdaq
- Market Cap
- EXEL 10.4B
- AM 8.5B
- IPO Year
- EXEL 2000
- AM 2014
- Fundamental
- Price
- EXEL $37.88
- AM $18.82
- Analyst Decision
- EXEL Buy
- AM Hold
- Analyst Count
- EXEL 22
- AM 3
- Target Price
- EXEL $44.00
- AM $18.50
- AVG Volume (30 Days)
- EXEL 2.4M
- AM 2.3M
- Earning Date
- EXEL 10-28-2025
- AM 10-29-2025
- Dividend Yield
- EXEL N/A
- AM 4.78%
- EPS Growth
- EXEL 81.76
- AM 18.64
- EPS
- EXEL 2.08
- AM 0.95
- Revenue
- EXEL $2,230,005,000.00
- AM $1,224,620,000.00
- Revenue This Year
- EXEL $9.10
- AM $3.16
- Revenue Next Year
- EXEL $12.47
- AM $3.79
- P/E Ratio
- EXEL $18.54
- AM $19.84
- Revenue Growth
- EXEL 10.73
- AM 7.09
- 52 Week Low
- EXEL $25.17
- AM $14.22
- 52 Week High
- EXEL $49.62
- AM $19.82
- Technical
- Relative Strength Index (RSI)
- EXEL 38.92
- AM 48.69
- Support Level
- EXEL $38.35
- AM $18.86
- Resistance Level
- EXEL $41.44
- AM $19.46
- Average True Range (ATR)
- EXEL 0.97
- AM 0.36
- MACD
- EXEL -0.26
- AM -0.08
- Stochastic Oscillator
- EXEL 2.48
- AM 8.93
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About AM Antero Midstream Corporation
Antero Midstream Corp is a midstream company that owns, operates, and develops midstream energy assets that service Antero Resources' production and completion activity in the Appalachian Basin located in West Virginia and Ohio. The company has two operating segments; the Gathering and Processing segment includes a network of gathering pipelines and compressor stations that collect and process production from Antero Resources wells in West Virginia and Ohio and the Water Handling segment includes two independent systems that deliver water from sources including the Ohio River, local reservoirs and several regional waterways. It derives a majority of its revenue from the Gathering and Processing segment.